BitFrontier Capital Holdings, Inc. Appoints Dr. Jordan P. Balencic as CEO to Spearhead Strategic Turnaround

BitFrontier Capital Holdings, Inc. (OTC: BFCH), a company previously focused on cryptocurrency mining and hosting services, has appointed Dr. Jordan P. Balencic as its Chief Executive Officer. This strategic move is part of a broader turnaround plan designed to overhaul the company's capital structure, business model, and overall value proposition to shareholders. Dr. Balencic, a physician entrepreneur with extensive experience in the health and wellness sector, is set to lead BFCH into a new era of growth and innovation.

Dr. Balencic's vision for BFCH includes a significant pivot towards consumer health innovation, targeting areas such as functional foods, nootropic beverages, supplements, and digital health technologies. The company is also focusing on eliminating over $2 million in legacy convertible note obligations to improve its capital structure and equity profile. Additionally, BFCH is undergoing a corporate rebranding to reflect its new strategic direction and is in the process of assembling a new Board of Directors to support this transition.

One of the key milestones in BFCH's turnaround strategy is its intention to qualify for OTCQB status in 2026. Achieving this would require the company to complete a PCAOB audit, maintain current public disclosures, and meet all eligibility criteria. OTCQB qualification is seen as a critical step in enhancing investor confidence and attracting institutional capital.

Dr. Balencic emphasized the importance of discipline and transparency in rebuilding BFCH into a credible, innovation-focused public company. The strategic actions underway are aimed at creating long-term value for shareholders and positioning BFCH as a leader in the health and wellness technology sector. All updates regarding the company's progress will be communicated through the OTC Markets Disclosure & News Service, in compliance with applicable securities laws.